Medaffcon Makes Medtech Measurable When Data Determines Market Access
Medaffcon brings to the health technology market the kind of effectiveness and cost-conscious thinking well established in the pharmaceutical industry.
Medaffcon’s article in the latest biobanking magazine
Medaffcon pioneering biobank and real-world evidence research efforts in Finland
The newest Biobanking in Finland & Personalized Medicine magazine has now been published.
In the magazine, our experts explain why Finland is the ideal country to conduct biobank and real-world evidence (RWE) research. The article also summarizes briefly the results of our recent biobank report.
The magazine itself gives a comprehensive picture of biobanks and biobank research.
Biobanking in Finland & Personalized Medicine
Read the digital version of the whole magazine here. You can find our article from the pages 22-23.
